SHARE

Major factors driving growth of the global anastomosis devices market is increasing number of surgeries such as coronary artery bypass surgery (CABG) and bowel resection and increasing demand from geriatric population for minimal invasive surgeries.

Global anastomosis devices market is segmented on the basis of product type, application, and region.

On the basis of product type, the global anastomosis devices market is segmented into reusable and disposable. The disposable segment is expected to account for highest share in the global anastomosis devices market in terms of revenue. The reusable segment is projected to register highest CAGR over the forecast period.

On the basis of application, the global anastomosis devices market is segmented into cardiovascular surgeries, gastrointestinal surgery, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries. The cardiovascular surgeries segment is expected to account for highest share in the global anastomosis devices market in terms of revenue. The gastrointestinal surgery segment is projected to register highest CAGR over the forecast period.

On the basis of region, the global anastomosis devices market is segmented into, North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Do Inquiry of the Report Here: https://marketresearch.biz/report/anastomosis-devices-market/#inquiry

Market in North America is expected to account for major revenue share in the global anastomosis devices market. This can be attributed to increasing government initiatives with favorable reimbursement policies. Europe market accounts for second-largest revenue share in the global anastomosis devices market. Asia Pacific market is estimated to register highest CAGR in terms of revenue over the forecast period. This can be attributed to increasing government expenditure on healthcare sector and presence of prominent players operating emerging economies in this region.

Key players operating in global anastomosis devices market include LivaNova PLC., Vitalitec International Inc., Dextera Surgical Inc., Synovis Micro Alliance, Inc., Medtronic PLC, Ethicon US, LLC., Sorin Group USA, Inc., MAQUET GmbH, Guidant Group, Inc., and Terumo Corporation

LEAVE A REPLY

Please enter your comment!
Please enter your name here